Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms-Reference-Cited by-同舟云学术

Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms

Published:2018-08-01 Issue:12 Volume:97 Page:2437-2445
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Knauf Wolfgang, ,Aldaoud Ali,Hutzschenreuter Ulrich,Klausmann Martine,Dille Stephanie,Wetzel Natalie,Jänicke Martina,Marschner Norbert^ORCID

Funder

Celgene GmbH

Mundipharma GmbH

Onkovis GmbH

Roche

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-018-3449-8/fulltext.html

Reference32 articles.

1. Rajkumar SV, Kumar S (2016) Multiple myeloma: diagnosis and treatment. Mayo Clin Proc 91:101–119. https://doi.org/10.1016/j.mayocp.2015.11.007

2. Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (2017) Krebs in Deutschland 2013/2014. Häufigkeiten und Trends, 11. Ausgabe. Robert Koch-Institut, Berlin

3. Rajkumar SV (2011) Treatment of multiple myeloma. Nat Rev Clin Oncol 8:479–491. https://doi.org/10.1038/nrclinonc.2011.63

4. Palumbo A, Anderson K (2011) Multiple Myeloma. N Engl J Med 364:1046–1060. https://doi.org/10.1056/NEJMra1011442

5. Kuhr K, Wirth D, Srivastava K, Lehmacher W, Hellmich M (2016) First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany. Eur J Clin Pharmacol 72:257–265. https://doi.org/10.1007/s00228-015-1998-5

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in outcome of patients with advanced non-clear cell renal cell carcinoma from the tyrosine kinase inhibitor era to the immuno-oncology era;International Journal of Clinical Oncology;2024-08-14

2. Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution;Cancers;2023-11-02

3. Real‐world experience of novel multiple myeloma treatments in a large, single‐center cohort in Finland;eJHaem;2023-10-06

4. The real-world outcomes of multiple myeloma treated with elotuzumab, pomalidomide, and dexamethasone;2023-08-18

5. Comparison of Outcomes Between Therapeutic Combinations Based on Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitor Monotherapy for First-Line Therapy of Patients with Advanced Renal Cell Carcinoma Outside of Clinical Trials: A Real-World Retrospective Multi-Institutional Study;Targeted Oncology;2023-03